2′-Deoxyuridine 5′-mono-phos-phate disodium salt

We are 2′-Deoxyuridine 5′-mono-phos-phate disodium salt CAS:42155-08-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2'-Deoxyuridine 5'-mono-phos-phate disodium salt
CAS.NO:42155-08-8
Synonyms:2'-Deoxyuridine 5'-monophosphate disodium salt
2'-Deoxyuridine 5'-mono-phos-phate disodium salt
Molecular Formula:C9H11N2Na2O8P
Molecular Weight:352.14600
 
Physical and Chemical Properties:
Density:1.742
 
Specification:
Appearance:White or off-white crystalline powder
Assay(HPLC):≥98.0%
Loss on drying:≤25%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is used by the enzyme thymidylate synthetase (TS) (EC 2.1.1.45) for the de novo production of dTMP. dUMP is used as the reference substrate in studies of dUMP analogues in potential chemotherapy applications.

2'-Deoxyuridine 5'-mono-phos-phate disodium salt


Related News: Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.2491-17-0 At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.4-Chloro-2-fluorobenzoic acid At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.2,6-Dimethylpyrazine CAS:108-50-9 At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.

Related Products
Product Name
3-Aminobenzotrifluoride View Details
4-benzhydryloxy-1-methylpiperidine,hydrochloride View Details
(Benzothiazol-2-yl)-(Z)-2-trityloxyimino-2-(2-aminothiazole-4-yl)-thioacetate View Details
2,4-Bis(phenylsulfonyl)phenol manufacturer 3,5-Difluorotoluene manufacturer Teriparatide acetate manufacturer 2-Nitrobenzyl alcohol manufacturer D-Alanine manufacturer